Abbott Laboratories

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 21:00:13 16/07/2024 BST			5-day change	1st Jan Change
102.7 ^USD	-0.23%		+1.06%	-6.68%

07-15	Equity Markets Higher After Fed Chair Powell's Comments	MT
07-15	Equity Markets Rise Intraday After Fed Chair Powell's Comments	MT

Abbott Laboratories Announces Quarterly Cash Dividend, Payable on February 15, 2015

January 29, 2015 at 01:05 pm

On Dec. 12, 2014, the board of directors of Abbott Laboratories increased the company's quarterly dividend to $0.24 per share from $0.22 per share. The cash dividend is payable Feb.

15, 2015, to shareholders of record at the close of business on Jan. 15, 2015.

Latest news about Abbott Laboratories

Equity Markets Higher After Fed Chair Powell's Comments	07-15	MT
Equity Markets Rise Intraday After Fed Chair Powell's Comments	07-15	MT
Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says	07-15	MT
Stocks Gain Pre-Bell Ahead of Key Earnings; Asia Mixed, Europe Down	07-15	MT
S&P 500 Rises Week-to-Week, Closes Near Highs Despite Mixed Inflation Data, Bank Earnings	07-12	MT
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $118 From $121	07-10	MT
DexCom, Inc. : A Must-Have Tool for Diabetes Care	07-10
That's not so bad, is it?	07-08
Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating	07-02	MT
Abbott Laboratories(NYSE:ABT) dropped from Russell Top 200 Growth Index	06-30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 3000 Growth Index	06-30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 3000E Growth Index	06-30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 1000 Growth Index	06-30	CI
Abbott Laboratories(NYSE:ABT) dropped from Russell 1000 Growth-Defensive Index	06-30	CI
Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health	06-20	CI
Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15	06-14	MT
Abbott Laboratories Declares Quarterly Common Dividend, Payable on August 15, 2024	06-14	CI
Abbott Laboratories Says US FDA Approved 2 Over-The-Counter Continuous Glucose Monitoring Wearable Systems	06-10	MT
US FDA clears Abbott's continuous glucose monitors for over-the-counter use	06-10	RE
Abbott Receives U.S. FDA Clearance for Two New Over-The-Counter Continuous Glucose Monitoring Systems	06-10	CI
U.S. FDA set to reorganize its food division starting October	05-30	RE
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115	05-30	MT
Medtronic beats quarterly profit estimates on medical devices strength	05-23	RE
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating	05-22	MT
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit	05-15	MT

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

18/07/2024 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Abbott Laboratories

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

102.7 USD

Average target price

124.8 USD

Spread / Average Target

+21.48%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-6.68%	179B
MEDTRONIC PLC	-5.20%	100B
BECTON, DICKINSON AND COMPANY	-5.38%	66.67B
HOYA CORPORATION	+18.16%	44.81B
DEXCOM, INC.	-6.47%	46.16B
CENCORA, INC.	+9.74%	44.38B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.01%	29.53B
TERUMO CORPORATION	+22.31%	25.83B
WEST PHARMACEUTICAL SERVICES, INC.	-6.53%	23.97B
ZIMMER BIOMET HOLDINGS, INC.	-11.70%	22.11B

Other Medical Equipment, Supplies & Distribution